TRINOMAB
Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel fully native human monoclonal antibody (mAb) drugs. The company's core technology is known as HitmAb, a proprietary technology platform with differentiated advantages and high efficiency for the discovery of fully native human mAbs against infectious diseases, autoimmune disorders, malignant tumors, and other human diseases.
TRINOMAB
Social Links:
Industry:
Health Care
Founded:
2015-01-01
Address:
Zhuhai, Guangdong, China
Country:
China
Website Url:
http://www.trinomab.com
Total Employee:
11+
Status:
Active
Total Funding:
1.05 B CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content HSTS Nginx Microsoft Azure DNS DigiCert SSL RapidSSL Alibaba
Similar Organizations
Caregiver
Caregiver is a behavioral health company,
Doctor Anywhere
Doctor Anywhere is a telehealth company .
FiNC
FiNC combines data analysis, rich content, and social elements to help users log, understand, manage, and improve their health and wellness.
Fresenius Medical Care North America
Fresenius Medical Care North America provides healthcare services to people with renal and other chronic conditions.
Kenbi
Kenbi is a nurse centric outpatient care company.
La Renon
La Renon is a global healthcare company.
Better Health Group
Better Health Group is a healthcare company.
Thrive Health Tech
Thrive Health Tech is a healthcare-focused mobile company.
Sanara MedTech
Sanara MedTech develop, market, and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings.
Current Employees Featured
Founder
Investors List
Guolian Capital
Guolian Capital investment in Venture Round - Trinomab
Jiaxing Weilong Equity Investment
Jiaxing Weilong Equity Investment investment in Venture Round - Trinomab
Shenhong Gejin
Shenhong Gejin investment in Venture Round - Trinomab
Kingray Capital
Kingray Capital investment in Venture Round - Trinomab
Haichuang Anda
Haichuang Anda investment in Venture Round - Trinomab
Xintaige
Xintaige investment in Venture Round - Trinomab
China Medical System Holdings Limited
China Medical System Holdings Limited investment in Venture Round - Trinomab
Yifeng Capital
Yifeng Capital investment in Venture Round - Trinomab
Zhuhai Gree Financial Investment Management
Zhuhai Gree Financial Investment Management investment in Venture Round - Trinomab
Qinwan Capital
Qinwan Capital investment in Venture Round - Trinomab
Official Site Inspections
http://www.trinomab.com Semrush global rank: 5.73 M Semrush visits lastest month: 1.24 K
- Host name: 47.106.64.40
- IP address: 47.106.64.40
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Trinomab"
Trinomab - Crunchbase Company Profile & Funding
Trinomab is a Healthcare company. Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel fully native human monoclonal antibody (mAb) drugs.See details»
Trinomab - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 29, 2022: Venture Round - …See details»
Trinomab - Products, Competitors, Financials, Employees, …
Trinomab is a clinical-stage biopharmaceutical company with a focus on the development of innovative, original natural human monoclonal antibody drugs. Use the CB Insights Platform to …See details»
Trinomab (Hong Kong) Biotech Co., Limited - hkstp.org
The information provided on this page is for reference only. Please refer to the latest information published by the partner company.See details»
Trinomab - Crunchbase
Trinomab is a Healthcare company. Trinomab, Curon Biopharma, KSEP, Oranger, and Shengmei Biotech operate in the healthcare industry.See details»
Trinomab(Zhuhai) - PitchBook
Trinomab(Zhuhai) General Information Description. Developer of antibody biopharmaceuticals designed for related medical research services. The company's research revolves around …See details»
Trinomab Biotech Co., Ltd | Expanded Access Navigator - Reagan …
Trinomab is dedicated to discovering and developing novel native human monoclonal antibody (mAb) drug. Trinomab’s lead product, TNM002 injection, is the first recombinant native human …See details»
Trinomab Biotech Co. Ltd. - BioCentury Company Profiles - BCIQ
Trinomab Biotech Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Trinomab Stock Price, Funding, Valuation, Revenue & Financial …
See Trinomab funding rounds, investors, investments, exits and more. Evaluate their financials based on Trinomab's post-money valuation and revenue.See details»
Equity investment in and Establishment of a Joint Venture with …
Apr 18, 2021 The Board of Directors (the “Directors”) of China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that the …See details»
Fully Native Human mAb Drug Developer Trinomab Raises CNY …
Nov 29, 2022 Trinomab (Chinese: 泰诺麦博), a fully native human monoclonal antibody (mAb) drug developer, recently announced that it had completed a pre-IPO funding round worth …See details»
China Medical System (867.HK) Collaborated with Trinomab in …
On 21 June 2021, China Medical System Holdings Limited (“CMS”, together with its subsidiaries, the “Group”) entered into a supplementary agreement with the innovative biotech company …See details»
Trinomab - Updates, News, Events, Signals & Triggers - Crunchbase
Trinomab is a Healthcare company. Start Free Trial . Chrome ExtensionSee details»
Horizon Discovery CHOSOURCE Cell Line Supports Trinomab …
WALTHAM, Mass. – February, 4, 2021 – Horizon Discovery, a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ …See details»
Chinese biotech firm Trinomab closes $104m pre-IPO round to …
Nov 29, 2022 Trinomab Biotech, a Chinese clinical-stage biopharmaceutical firm with operations globally, announced on Tuesday the completion of its pre-IPO financing at about 750 million …See details»
PerkinElmer’s Horizon Discovery Cell Line Supports Trinomab …
Feb 4, 2021 WALTHAM, Mass.–PerkinElmer announced that its Horizon Discovery CHOSOURCE™ CHO-K1GS knockout cell line licensed by Trinomab Biotech. Co., Ltd., of …See details»
PerkinElmer’s Horizon Discovery CHOSOURCE Cell Line Supports …
Feb 4, 2021 WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ …See details»
SPINNING TECHNOLOGY – LincSpun Group
LincSpuns patented technology involves the spinning of two continuous filaments with a staple fibre base, this strengthens and supports the yarn, dramatically stabilising the fabric. "Merino …See details»
Venture Round - Trinomab - 2022-11-29 - Crunchbase
Nov 29, 2022 Trinomab raised $104736901 on 2022-11-29 in Venture Round. 36kr.com — Technomicrob completed a Pre-IPO round of financing of about 750 million yuan, focusing on …See details»
LincSpun and NILIT introduce highperformance …
May 30, 2011 Trinomax AQ is made from three components: natural Merino wool, textured NILIT nylon 6.6 and NILIT Aquarius. Twisted together, using a technology proprietary to LincSpun, …See details»